BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Ibutilide

Potentially Fatal Arrhythmias

Experienced Personnel/Equipped Facility

Potentially Fatal Arrhythmias: have occurred and requires administration in a setting of continuous ECG monitoring and personnel trained in identification and treatment of acute ventricular arrhythmias.

Patient Selection: Patients with chronic atrial fibrillation have a strong tendency to revert after conversion to sinus rhythm and treatment to maintain sinus rhythms carry risks. Patients for ibutilide therapy should be carefully selected.


MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA

  • Patients with atrial fibrillation of > 2 to 3 days must be adequately anticoagulated for > 2 weeks
  • Assess benefit/risk ratio of maintenance therapy

Patient Counseling Information

Package Inserts

Ibutilide

Additional Information

Updated January 2018